| Literature DB >> 35277131 |
Pei-Jing Yang1, Ming-Feng Hou2,3, Fu Ou-Yang2, Eing-Mei Tsai4,5, Tsu-Nai Wang6,7.
Abstract
BACKGROUND: The trend of women suffering from early-onset breast cancer is increasing in Taiwan. The association of early-onset breast cancer with body mass index (BMI), menarche, and menopausal status has focused interest on the field of cancer epidemiology; however, few studies have explored the interaction of these factors on early-onset risk. This study aimed to estimate the interaction effects of BMI, menarche, and menopausal status on 40-year-old early-onset breast cancer.Entities:
Keywords: BMI; Breast cancer; Early-onset; Epidemiology; Interaction; Menarche; Menopause
Mesh:
Year: 2022 PMID: 35277131 PMCID: PMC8917681 DOI: 10.1186/s12885-022-09361-2
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Fig. 1The flow chart for recruiting female breast cancer participants
The sociodemographic characteristics between early-onset and late-onset breast cancer participants
| 35.87 ± 4.13 | 54.24 ± 8.68 | < 0.001 | < 0.001 | |
| < 0.001 | < 0.001 | |||
| BMI < 24 | 100 (76.3) | 361 (56.1) | ||
| BMI ≥ 24 | 31 (23.7) | 282 (43.9) | ||
| < 0.001 | < 0.001 | |||
| < college | 43 (32.8) | 438 (68.0) | ||
| ≥ college | 88 (67.2) | 206 (32.0) | ||
| < 0.001 | < 0.001 | |||
| Unmarried/Divorce/Widowed | 49 (37.4) | 125 (19.4) | ||
| Married | 82 (62.6) | 519 (80.6) | ||
| 0.677 | 1.000 | |||
| Never | 124 (94.7) | 615 (95.5) | ||
| Ever | 7 (5.3) | 29 (4.5) | ||
| 1.000 | 1.000 | |||
| Never | 128 (97.7) | 627 (97.4) | ||
| Ever | 3 (2.3) | 17 (2.6) | ||
| 0.035 | 0.875 | |||
| None | 67 (51.1) | 265 (41.1) | ||
| Yes | 64 (48.9) | 379 (58.9) | ||
| < 0.001 | < 0.001 | |||
| Premenopause | 79 (60.3) | 108 (16.8) | ||
| Peri-/Postmenopause | 52 (39.7) | 536 (83.2) | ||
| < 0.001 | < 0.001 | |||
| Premenopause | 67 (67.0) | 65 (18) | ||
| Peri-/Postmenopause | 33 (33.0) | 296 (82) | ||
| 0.001 | 0.025 | |||
| Premenopause | 12 (38.7) | 43 (15.2) | ||
| Peri-/Postmenopause | 19 (61.3) | 239 (84.8) | ||
| 0.149 | 1.000 | |||
| Never | 119 (90.8) | 555 (86.2) | ||
| Ever | 12 (9.2) | 89 (13.8) | ||
| < 0.001 | < 0.001 | |||
| Nulliparous | 52 (39.7) | 79 (12.3) | ||
| Parous | 79 (60.3) | 565 (87.7) | ||
| 0.001 | 0.025 | |||
| One | 21 (26.6) | 72 (12.7) | ||
| More than one | 58 (73.4) | 493 (87.3) | ||
| < 0.001 | 0.001 | |||
| < 27 years | 23 (29.1) | 303 (53.7) | ||
| ≥ 27 years | 56 (70.9) | 261 (46.3) | ||
| 0.003 | 0.075 | |||
| Never | 21 (26.6) | 251 (44.4) | ||
| Ever | 58 (73.4) | 314 (55.6) | ||
| < 0.001 | < 0.001 | |||
| 1 ~ 2 times a week | 113 (86.3) | 619 (96.1) | ||
| 3 ~ 6 times a week | 18 (13.7) | 25 (3.9) | ||
| 0.559 | 1.000 | |||
| Never | 98 (74.8) | 497 (77.2) | ||
| Ever | 33 (25.2) | 147 (22.8) | ||
| 0.073 | 1.000 | |||
| None | 96 (73.3) | 517 (80.3) | ||
| Yes | 35 (26.7) | 127 (19.7) |
SD Standard deviation, BMI Body mass index
aP-values were calculated for continuous variables by Independent sample t-test and for categorical variables by Chi-square test or Fisher's exact test
The clinical characteristics between early-onset and late-onset breast cancer participants
| < 0.001 | 0.0048 | |||
| Fatty + Mildly dense | 10 (7.9) | 99 (16.5) | ||
| Moderately | 84 (66.7) | 426 (71.0) | ||
| Extremely | 32 (25.4) | 75 (12.5) | ||
| 0.322 | 1.000 | |||
| Luminal A | 78 (65.5) | 379 (62.0) | ||
| Luminal B | 22 (18.5) | 107 (17.5) | ||
| HER2-enriched | 7 (5.9) | 71 (11.6) | ||
| Triple negative | 12 (10.1) | 54 (8.8) | ||
| 0.822 | 1.000 | |||
| 0/I/II | 108 (84.4) | 529 (83.6) | ||
| III/IV | 20 (15.6) | 104 (16.4) | ||
| 0.761 | 1.000 | |||
| Well differentiated | 16 (13.7) | 85 (13.8) | ||
| Moderately differentiated | 65 (55.6) | 321 (52.1) | ||
| Poorly differentiated | 36 (30.8) | 210 (34.1) | ||
| 0.251 | 1.000 | |||
| ≤ 2 cm | 68 (54.4) | 371 (59.9) | ||
| > 2 cm | 57 (45.6) | 248 (40.1) | ||
| 0.055 | 1.000 | |||
| None | 9 (8.9) | 91 (16.4) | ||
| Yes | 92 (91.1) | 465 (83.6) | ||
| 0.272 | 1.000 | |||
| ER-negative | 22 (17.5) | 138 (21.8) | ||
| ER-positive | 104 (82.5) | 494 (78.2) | ||
| 0.270 | 1.000 | |||
| PR-negative | 37 (29.8) | 220 (35.0) | ||
| PR-positive | 87 (70.2) | 409 (65.0) | ||
| 0.292 | 1.000 | |||
| HER2-negative | 90 (75.6) | 433 (70.9) | ||
| HER2-positive | 29 (24.4) | 178 (29.1) |
TNM stage TNM classification of malignant tumors, ER Estrogen receptor, PR Progesterone receptor, HER2 Human epidermal growth factor receptor 2. aP-values were calculated for categorical variables by Chi-square test
Fig. 2The risk of 40-years-old early-onset breast cancer by per age at menarche. The black dots represent the odds ratios (ORs) for the risk of 40-years-old early-onset breast cancer by per age at menarche and the vertical dotted lines represent 95% confidence intervals (CIs)
The association of 40-year-old early-onset breast cancer with sociodemographic characteristics and correlated with menarcheal age
| BMI < 24 | 2.52 (1.64–3.88) | < 0.001 | 1.49 (1.24–1.78) | < 0.001 | 1.76 (1.09–2.84) | 0.020 | 1.26 (1.03–1.55) | 0.028 |
| BMI ≥ 24 | 1 | 1.41 (1.09–1.83) | 0.008 | 1 | 1.23 (0.92–1.63) | 0.162 | ||
| < college | 1 | 1.20 (0.96–1.50) | 0.110 | 1 | 1.15 (0.89–1.47) | 0.282 | ||
| ≥ college | 4.35 (2.92–6.50) | < 0.001 | 1.36 (1.12–1.65) | 0.002 | 2.54 (1.62–3.98) | < 0.001 | 1.30 (1.04–1.62) | 0.022 |
| Unmarried/Divorce/Widowed | 2.48 (1.66–3.72) | < 0.001 | 1.28 (0.98–1.67) | 0.066 | 0.88 (0.44–1.77) | 0.726 | 1.05 (0.78–1.40) | 0.749 |
| Married | 1 | 1.49 (1.25–1.77) | < 0.001 | 1 | 1.32 (1.08–1.61) | 0.008 | ||
| None | 1.50 (1.03–2.18) | 0.036 | 1.45 (1.18–1.78) | < 0.001 | 1.40 (0.90–2.17) | 0.138 | 1.27 (0.99–1.62) | 0.058 |
| Yes | 1 | 1.37 (1.13–1.67) | 0.001 | 1 | 1.20 (0.96–1.51) | 0.113 | ||
| Premenopause | 7.54 (5.02–11.32) | < 0.001 | 1.09 (0.87–1.37) | 0.436 | 4.59 (2.94–7.16) | < 0.001 | 1.12 (0.86–1.46) | 0.397 |
| Peri-/Postmenopause | 1 | 1.39 (1.13–1.71) | 0.002 | 1 | 1.35 (1.09–1.69) | 0.007 | ||
| Premenopause | 9.25 (5.63–15.18) | < 0.001 | 1.20 (0.91–1.59) | 0.205 | 6.47 (3.76–11.13) | < 0.001 | 1.12 (0.83–1.51) | 0.446 |
| Peri-/Postmenopause | 1 | 1.45 (1.09–1.92) | 0.010 | 1 | 1.42 (1.05–1.91) | 0.022 | ||
| Premenopause | 3.51 (1.59–7.75) | 0.002 | 1.22 (0.74–2.02) | 0.435 | 2.18 (0.93–5.12) | 0.073 | 1.28 (0.67–2.42) | 0.457 |
| Peri-/Postmenopause | 1 | 1.34 (0.98–1.84) | 0.067 | 1 | 1.27 (0.91–1.78) | 0.161 | ||
| Nulliparous | 4.71 (3.09–7.18) | < 0.001 | 1.18 (0.91–1.53) | 0.220 | 3.10 (1.53–6.29) | 0.002 | 1.01 (0.75–1.36) | 0.964 |
| Parous | 1 | 1.52 (1.27–1.81) | < 0.001 | 1 | 1.33 (1.09–1.62) | 0.005 | ||
| One | 2.48 (1.42–4.33) | 0.001 | 1.73 (1.14–2.63) | 0.011 | 1.60 (0.85–3.01) | 0.149 | 1.59 (0.99–2.53) | 0.054 |
| More than one | 1 | 1.46 (1.20–1.78) | < 0.001 | 1 | 1.28 (1.02–1.60) | 0.033 | ||
| < 27 years | 1 | 1.33 (0.99–1.79) | 0.060 | 1 | 1.19 (0.85–1.67) | 0.318 | ||
| ≥ 27 years | 2.83 (1.69–4.72) | < 0.001 | 1.52 (1.21–1.91) | < 0.001 | 1.28 (0.70–2.33) | 0.421 | 1.35 (1.04–1.73) | 0.022 |
| Never | 1 | 1.29 (0.91–1.83) | 0.148 | 1 | 1.21 (0.83–1.76) | 0.333 | ||
| Ever | 2.21 (1.31–3.74) | 0.003 | 1.62 (1.32–1.99) | < 0.001 | 1.87 (1.06–3.28) | 0.030 | 1.38 (1.09–1.76) | 0.008 |
| 1 ~ 2 times a week | 1 | 1.32 (1.14–1.53) | < 0.001 | 1 | 1.19 (1.00–1.41) | 0.055 | ||
| 3 ~ 6 times a week | 3.94 (2.08–7.47) | < 0.001 | 1.72 (1.10–2.70) | 0.019 | 1.97 (0.91–4.26) | 0.085 | 1.20 (0.47–3.04) | 0.707 |
| Never | 1 | 1.37 (1.17–1.61) | < 0.001 | 1 | 1.17 (0.96–1.42) | 0.117 | ||
| Ever | 1.14 (0.74–1.76) | 0.559 | 1.53 (1.16–2.03) | 0.003 | 1.11 (0.68–1.83) | 0.670 | 1.44 (1.03–2.00) | 0.031 |
| None | 1 | 1.36 (1.16–1.60) | < 0.001 | 1 | 1.20 (0.99–1.46) | 0.062 | ||
| Yes | 1.48 (0.96–2.29) | 0.074 | 1.56 (1.15–2.11) | 0.004 | 1.43 (0.87–2.36) | 0.163 | 1.32 (0.92–1.91) | 0.133 |
BMI body mass index, OR odds ratio, CI confidence interval
aCrude odds ratio (cOR) was calculated by multivariable logistic regression
bAdjusted for BMI, education, marriage, physical activity, menopausal status, and parity, shown as aOR (95% CI)
Fig. 3The interaction effect between BMI and menopausal status on 40-year-old early-onset breast cancer risk. Odds ratios (ORs) were calculated by multivariable logistic regression and adjusted for education, marriage, physical activity, and parity. The vertical dotted lines represent 95% confidence intervals (CIs). *P-values < 0.05, **P-values < 0.01